Dapagliflozin (10mg Tab)

DRUG13 trials

Sponsors

Yung NA, Centenario Hospital Miguel Hidalgo, Hospital de Clinicas de Porto Alegre, University of Edinburgh, Seug yun Yoon, MD

Conditions

Acute Heart Failure (AHF)AdolescentAlbuminuriaAnemiaAngina With Non-Obstructive Coronary Artery DiseaseChronic Kidney Disease (Mild to Moderate)Congestive Heart Failure AcuteCoronary Microvascular Dysfunction (CMD)

Phase 1

Efficacy and Safety of Dapagliflozin as an Adjunct to Conventional Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Not yet recruitingNCT07901309

Tanta UniversityRheumatoid Arthritis (RA

Start: 2026-10-30End: 2027-07-01Target: 100Updated: 2026-10-28

Phase 2

Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer

RecruitingNCT07310433

Yung NAMetastatic Prostate Cancer, Prostate Cancer

Start: 2026-05-01End: 2030-04-30Target: 68Updated: 2026-10-28

POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

Not yet recruitingNCT07469722

Hospital de Clinicas de Porto AlegreAcute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect +3

Start: 2026-03-23End: 2028-07-01Target: 128Updated: 2026-03-18

Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes

Not yet recruitingNCT07516847

Seug yun Yoon, MDAnemia, Myelodysplastic Syndromes (MDS)

Start: 2026-09-01End: 2029-09-01Target: 37Updated: 2026-04-08

Dapagliflozin in Living-Donor Kidney Transplant Recipients

Active, not recruitingNCT07555106

University of GuadalajaraKidney Transplant, Kidney Transplant Failure

Start: 2024-09-15End: 2026-09-30Updated: 2026-04-29

Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves

CompletedNCT07610174

Kafrelsheikh UniversityHeart Failure, Heart Valve Prosthesis

Start: 2025-06-02End: 2026-04-29Updated: 2026-05-29

aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

Not yet recruitingNCT07741890

The Christ HospitalAngina With Non-Obstructive Coronary Artery Disease, Coronary Microvascular Dysfunction (CMD)

Start: 2026-09-01End: 2029-03-01Target: 120Updated: 2026-08-03

Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome

Not yet recruitingNCT07810998

Tanta UniversityPoly Cystic Ovary Syndrome

Start: 2026-09-10End: 2027-05-10Target: 60Updated: 2026-09-09

Phase 4

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

RecruitingNCT07405216

Centenario Hospital Miguel HidalgoAdolescent, Albuminuria, Chronic Kidney Disease (Mild to Moderate) +1

Start: 2026-04-23End: 2027-10-30Target: 200Updated: 2026-04-27

Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin Resistance

Not yet recruitingNCT07891234

Sherihan AboElyazed Mohamed KhalilMAFLD in Prediabetes and Diabetes

Start: 2026-10-01End: 2027-10-01Target: 66Updated: 2026-10-23

Unknown Phase

Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

RecruitingNCT07491718

University of EdinburghTakotsubo Cardiomyopathy

Start: 2025-08-08End: 2028-08-09Target: 100Updated: 2026-09-18

DP-DCT 1.0：A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform

Not yet recruitingNCT07595289

The Third Xiangya Hospital of Central South UniversityType 2 Diabetes Mellitus (T2DM)

Start: 2026-08-01End: 2027-08-01Target: 120Updated: 2026-05-19

Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver Disease

CompletedNCT07881796

Shalamar HospitalNon-Alcoholic Fatty Liver Disease

Start: 2026-04-15End: 2026-09-15Updated: 2026-10-19